Evidence map›Paper›PMID 41126992›Full record

ArticleCardiovascular therapeutics2025

Endovenous Laser Ablation of Insufficient Superficial Veins in Patients After Deep Vein Thrombosis Recanalisation.

Srdjan Babic, Jovan Petrovic, Masa Petrovic, Slobodan Pesic, Slobodan Tanaskovic, Ana Cvetkovic, Predrag Gajin, Nenad Ilijevski

Abstract read
In one paragraph

Article in Cardiovascular therapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Srdjan BabicDepartment of Vascular Surgery, Vascular Surgery Clinic, Institute for Cardiovascular Diseases "Dedinje", Belgrade, Serbia.ORCID https://orcid.org/0000-0001-9659-9190
Jovan PetrovicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.ORCID https://orcid.org/0000-0002-9032-6228
Masa PetrovicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.ORCID https://orcid.org/0000-0003-1709-8449
Slobodan PesicDepartment of Vascular Surgery, Vascular Surgery Clinic, Institute for Cardiovascular Diseases "Dedinje", Belgrade, Serbia.ORCID https://orcid.org/0000-0002-3219-1396
Slobodan TanaskovicDepartment of Vascular Surgery, Vascular Surgery Clinic, Institute for Cardiovascular Diseases "Dedinje", Belgrade, Serbia.ORCID https://orcid.org/0000-0003-4216-6693
Ana CvetkovicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.ORCID https://orcid.org/0000-0001-5933-9453
Predrag GajinDepartment of Vascular Surgery, Vascular Surgery Clinic, Institute for Cardiovascular Diseases "Dedinje", Belgrade, Serbia.ORCID https://orcid.org/0000-0001-9707-8805
Nenad IlijevskiDepartment of Vascular Surgery, Vascular Surgery Clinic, Institute for Cardiovascular Diseases "Dedinje", Belgrade, Serbia.ORCID https://orcid.org/0000-0002-8200-9556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study is aimed at investigating the safety of endovenous laser ablation treatment in the superficial venous system and perforator venous system in patients with previous deep vein thrombosis. Methods: From February 2017 to January 2023, 28 patients (20 women) with an average age of 41.5 ± 8.6 years, insufficient great saphenous vein and previous deep vein thrombosis were treated. All patients were diagnosed based on previous ultrasound examinations. In this retrospective study, patients were indeed included if they met specific criteria. Preoperative evaluations and thrombophilia assessments were conducted. Results: Most patients had previous thrombosis in the popliteal vein (36.4%), while 31.8% had thrombosis in both the femoral and calf veins. Technical success was achieved in all patients, with concomitant procedures (closure of incompetent perforators and phlebectomies), and during follow-up (20 ± 16 months, range: 2-168 months), there were no signs of recanalisation of previously treated superficial veins. Patients were followed up at 1-month, 3-month, 6-month and 12-month intervals postprocedure. Recurrent deep vein thrombosis occurred in two (7%) patients after 26 and 31 months after treatment. Early complications included one (3.5%) case of endovenous heat-induced thrombosis Type II. Conclusions: Endovenous laser ablation is safe and effective in patients with resolved deep vein thrombosis when combined with appropriate anticoagulant therapy.

Indexed as

Endovascular ProceduresLaser TherapySaphenous VeinVenous InsufficiencyVenous ThrombosisAdultFemaleHumansMaleMiddle AgedRecurrenceRetrospective StudiesRisk FactorsTime FactorsTreatment Outcomedeep vein thrombosisendovenous ablationgreat saphenous veinthrombophiliavenous insufficiency

Identifiers

PMID41126992
PMCPMC12540011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.